Dr. Leary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-598-4615Fax+1 206-598-3036
Summary
- Dr. Peter Leary is a pulmonologist in Seattle and is affiliated with University of Washington Medical Center. He received his medical degree from Johns Hopkins University School of Medicine in 2005. He specializes in pulmonary vascular disease and is the director of the pulmonary vascular disease program at the University of Washington. Dr. Leary has a PhD in Epidemiology and is very active in grant funded research relevant to patients with pulmonary hypertension and heart failure.
Education & Training
- University of Washington School of Public HealthPhD, Epidemiology, 2013 - 2018
- University of Washington School of Public HealthMS, Epidemiology , 2010 - 2013
- University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2009
- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
- WA State Medical License 2009 - 2026
- American Board of Internal Medicine Pulmonary Disease
- National Board of Physicians and Surgeons Critical Care Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Clinical Trials
- Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
- OPsumit USers Registry Start of enrollment: 2014 Apr 30
- U.S. CTEPH Registry Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citations"This Patient Needs a Doctor, Not a Guideline!" The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement.Samuel G Rayner, Ryan J Tedford, Peter J Leary, Susanna Mak, Brian A Houston
American Journal of Respiratory and Critical Care Medicine. 2024-09-15 - 2 citationsFatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.Nicolas Philip, Xin Yun, Hongyang Pi, Samuel Murray, Zack Hill
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-03-01 - Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli.Zachary L Steinberg, Samuel G Rayner, Peter J Leary
Catheterization and Cardiovascular Interventions. 2024-01-01
Press Mentions
- COVID Vaccine for Patient with Rare Disease? Best Guess Is YesJanuary 21st, 2021
- Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular CarcinomaNovember 3rd, 2020
- I'm Aware That I'm Rare: Peter Leary, MD (PE Part 2 of 2)September 25th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
- Pulmonary Hypertension Association - PHAMember
- Pulmonary Vascular Research Institute - PVRIMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: